Component

Myricitrin-metabolizing intestinal isolates from one human donor

Context-specific entity; species, compartment and exposure are stated on each claim.

3 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

Read recorded mechanisms Open recursive mind map

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

Where it participates (unsigned role)

  1. Human-donor intestinal bacterial cultures yielded Myricetin through the reported deglycosylation route.

    Myricitrin / myricetin 3-O-rhamnoside → Myricetin source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Four active isolates selected from about 100 colonies from one healthy female donor; most identified as Escherichia.
    limitations
    Mass-spectrometric pathway assignment; no specific enzyme or population-wide conversion rate established.
    nutrient_topic
    Myricetin collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Myricetin
    plain_language
    Gut processing produces a chemically different molecule.
    primary_references
    Identification of the metabolites of myricitrin produced by human intestinal bacteria in vitro using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry. · 2014 · https://pubmed.ncbi.nlm.nih.gov/24882500/ · DOI 10.1517/17425255.2014.918954

    Myricetin: metabolism, immune signaling, redox chemistry and cross-nutrient mechanisms (2026-09-19) · lines 20–26

    AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Four active isolates selected from about 100 colonies from one healthy female donor; most identified as Escherichia. · source_derived_draft · unverified_draft

    ## myricetin-microbial-deglycosylation Gut processing produces a chemically different molecule. Human-donor intestinal bacterial cultures yielded Myricetin through the reported deglycosylation route. Model: Four active isolates selected from about 100 colonies from one healthy female donor; most identified as Escherichia. Limitations: Mass-spectrometric pathway assignment; no specific enzyme or population-wide conversion rate established. Evidence access: Primary abstract Identification of the metabolites of myricitrin produced by human intestinal bacteria in vitro using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry. · 2014 · https://pubmed.ncbi.nlm.nih.gov/24882500/ · DOI 10.1517/17425255.2014.918954
    Complete structured claim and evidence

  2. Human-donor intestinal bacterial cultures yielded Quercitrin / quercetin 3-O-rhamnoside through the reported dehydroxylation route.

    Myricitrin / myricetin 3-O-rhamnoside → Quercitrin / quercetin 3-O-rhamnoside source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Four active isolates selected from about 100 colonies from one healthy female donor; most identified as Escherichia.
    limitations
    Mass-spectrometric pathway assignment; no specific enzyme or population-wide conversion rate established.
    nutrient_topic
    Myricetin collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Myricetin
    plain_language
    Gut processing produces a chemically different molecule.
    primary_references
    Identification of the metabolites of myricitrin produced by human intestinal bacteria in vitro using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry. · 2014 · https://pubmed.ncbi.nlm.nih.gov/24882500/ · DOI 10.1517/17425255.2014.918954

    Myricetin: metabolism, immune signaling, redox chemistry and cross-nutrient mechanisms (2026-09-19) · lines 28–34

    AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Four active isolates selected from about 100 colonies from one healthy female donor; most identified as Escherichia. · source_derived_draft · unverified_draft

    ## myricetin-microbial-dehydroxylation Gut processing produces a chemically different molecule. Human-donor intestinal bacterial cultures yielded Quercitrin / quercetin 3-O-rhamnoside through the reported dehydroxylation route. Model: Four active isolates selected from about 100 colonies from one healthy female donor; most identified as Escherichia. Limitations: Mass-spectrometric pathway assignment; no specific enzyme or population-wide conversion rate established. Evidence access: Primary abstract Identification of the metabolites of myricitrin produced by human intestinal bacteria in vitro using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry. · 2014 · https://pubmed.ncbi.nlm.nih.gov/24882500/ · DOI 10.1517/17425255.2014.918954
    Complete structured claim and evidence

  3. Human-donor intestinal bacterial cultures yielded Quercetin through the reported subsequent deglycosylation route.

    Quercitrin / quercetin 3-O-rhamnoside → Quercetin source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Four active isolates selected from about 100 colonies from one healthy female donor; most identified as Escherichia.
    limitations
    Mass-spectrometric pathway assignment; no specific enzyme or population-wide conversion rate established.
    nutrient_topic
    Myricetin collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Myricetin
    plain_language
    Gut processing produces a chemically different molecule.
    primary_references
    Identification of the metabolites of myricitrin produced by human intestinal bacteria in vitro using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry. · 2014 · https://pubmed.ncbi.nlm.nih.gov/24882500/ · DOI 10.1517/17425255.2014.918954

    Myricetin: metabolism, immune signaling, redox chemistry and cross-nutrient mechanisms (2026-09-19) · lines 36–42

    AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Four active isolates selected from about 100 colonies from one healthy female donor; most identified as Escherichia. · source_derived_draft · unverified_draft

    ## myricetin-microbial-quercetin Gut processing produces a chemically different molecule. Human-donor intestinal bacterial cultures yielded Quercetin through the reported subsequent deglycosylation route. Model: Four active isolates selected from about 100 colonies from one healthy female donor; most identified as Escherichia. Limitations: Mass-spectrometric pathway assignment; no specific enzyme or population-wide conversion rate established. Evidence access: Primary abstract Identification of the metabolites of myricitrin produced by human intestinal bacteria in vitro using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry. · 2014 · https://pubmed.ncbi.nlm.nih.gov/24882500/ · DOI 10.1517/17425255.2014.918954
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards